
zzso is an inhibitor of zzso zzso zzso zzso zzso zzso zzso binding used in combination with zzso zzso factor zzso for zzso of zzso peripheral blood zzso stem cells zzso We developed a zzso zzso decision-making zzso that uses the zzso count in the peripheral blood on the fourth day of zzso administration zzso and the collection target zzso to decide between continuing zzso only zzso zzso or adding zzso to the zzso regimen zzso zzso aiming at the lowest zzso The zzso approach was more cost-effective with lower zzso It was possible to zzso for each zzso the maximum zzso for which the zzso approach is zzso generating an zzso for the use of zzso We validated this zzso in a cohort of 34 patients undergoing zzso zzso In all, 11 patients completed collection on the G approach and 23 patients on the zzso approach, with zzso of the patients completing collection within the predicted number of zzso zzso All patients who underwent transplantation zzso with minimal differences in zzso time between G and zzso zzso This validated zzso provides a potential zzso decision tool for the use of zzso in zzso zzso zzso 

